{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:36:06Z","timestamp":1793111766988,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000735","name":"University of Cambridge","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ajpath.2026.09.006","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:44:54Z","timestamp":1791906294000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tumor Necrosis Factor Receptor-2 Drives Tumoral Coagulation Factor Synthesis and Enhances Thrombosis in Clear-Cell Renal Cell Carcinoma"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3047-6224","authenticated-orcid":false,"given":"Rafia S.","family":"Al-Lamki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Willingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5990-1071","authenticated-orcid":false,"given":"Jordan S.","family":"Pober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aviva M.","family":"Tolkovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7774-8805","authenticated-orcid":false,"given":"John R.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2026.09.006_bib1","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.eururo.2018.01.005","article-title":"Predicting oncologic outcomes in renal cell carcinoma after surgery","volume":"73","author":"Leibovich","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajpath.2026.09.006_bib2","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2353\/ajpath.2010.091218","article-title":"Tumor necrosis factor receptor expression and signaling in renal cell carcinoma","volume":"177","author":"Al-Lamki","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2026.09.006_bib3","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ajpath.2024.02.019","article-title":"Tumor necrosis factor receptor-2 signals clear-cell renal carcinoma proliferation via phosphorylated 4E binding protein-1 and mitochondrial gene translation","volume":"194","author":"Al-Lamki","year":"2024","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2026.09.006_bib4","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1096\/fj.05-3841com","article-title":"TNFR1- and TNFR2-mediated signaling pathways in human kidney are cell type-specific and differentially contribute to renal injury","volume":"19","author":"Al-Lamki","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.ajpath.2026.09.006_bib5","doi-asserted-by":"crossref","first-page":"24111","DOI":"10.18632\/oncotarget.8125","article-title":"Tumor necrosis factor receptor 2-signaling in CD133-expressing cells in renal clear cell carcinoma","volume":"7","author":"Al-Lamki","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajpath.2026.09.006_bib6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4103\/0972-3919.90269","article-title":"Extensive tumor thrombus in a case of carcinoma lung detected by F18-FDG-PET\/CT","volume":"26","author":"Mudalsha","year":"2011","journal-title":"Indian J Nucl Med"},{"key":"10.1016\/j.ajpath.2026.09.006_bib7","doi-asserted-by":"crossref","first-page":"382","DOI":"10.14740\/cr943","article-title":"Left atrial tumor thrombus in a patient with squamous cell carcinoma of lung","volume":"10","author":"Murtaza","year":"2019","journal-title":"Cardiol Res"},{"key":"10.1016\/j.ajpath.2026.09.006_bib8","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.21037\/cdt.2017.09.16","article-title":"Tumor thrombus: incidence, imaging, prognosis and treatment","volume":"7","author":"Quencer","year":"2017","journal-title":"Cardiovasc Diagn Ther"},{"key":"10.1016\/j.ajpath.2026.09.006_bib9","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1016\/j.radcr.2024.06.051","article-title":"Tumour thrombosis of the left axillary vein due to infiltrative ductal carcinoma causing superior vena cava obstruction","volume":"19","author":"Sood","year":"2024","journal-title":"Radiol Case Rep"},{"key":"10.1016\/j.ajpath.2026.09.006_bib10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/sj.neo.7900263","article-title":"The hypercoagulable state of malignancy: pathogenesis and current debate","volume":"4","author":"Caine","year":"2002","journal-title":"Neoplasia"},{"key":"10.1016\/j.ajpath.2026.09.006_bib11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF02981929","article-title":"Pathogenesis of thrombosis in patients with malignancy","volume":"73","author":"Falanga","year":"2001","journal-title":"Int J Hematol"},{"key":"10.1016\/j.ajpath.2026.09.006_bib12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.urolonc.2022.11.021","article-title":"Renal cell carcinoma with tumor thrombus: a review of relevant anatomy and surgical techniques for the general urologist","volume":"41","author":"Almatari","year":"2023","journal-title":"Urol Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.ajpath.2026.09.006_bib13","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/S0049-3848(16)30101-3","article-title":"Management of cancer-associated disseminated intravascular coagulation","volume":"140","author":"Levi","year":"2016","journal-title":"Thromb Res"},{"key":"10.1016\/j.ajpath.2026.09.006_bib14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00281-011-0290-8","article-title":"Fibrinogen as a key regulator of inflammation in disease","volume":"34","author":"Davalos","year":"2012","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.ajpath.2026.09.006_bib15","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1182\/blood.V68.2.394.394","article-title":"Coagulation-cancer interaction in situ in renal cell carcinoma","volume":"68","author":"Zacharski","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2026.09.006_bib16","first-page":"52","article-title":"Role of tumor necrosis factor in the pathogenesis of intravascular coagulopathy of sepsis: potential new therapeutic implications","volume":"27","author":"Aderka","year":"1991","journal-title":"Isr J Med Sci"},{"key":"10.1016\/j.ajpath.2026.09.006_bib17","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.tcm.2005.07.004","article-title":"Two-way interactions between inflammation and coagulation","volume":"15","author":"Levi","year":"2005","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.ajpath.2026.09.006_bib18","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1097\/CCM.0b013e3181c98d21","article-title":"Inflammation and coagulation","volume":"38","author":"Levi","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ajpath.2026.09.006_bib19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.tcam.2012.06.003","article-title":"The reciprocal relationship between inflammation and coagulation","volume":"27","author":"O'Brien","year":"2012","journal-title":"Top Companion Anim Med"},{"issue":"Suppl 2","key":"10.1016\/j.ajpath.2026.09.006_bib20","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/S0049-3848(10)70153-5","article-title":"Inflammation and coagulation: an overview","volume":"127","author":"Petaja","year":"2011","journal-title":"Thromb Res"},{"key":"10.1016\/j.ajpath.2026.09.006_bib21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/beha.1999.0029","article-title":"Possible involvement of cytokines in diffuse intravascular coagulation and thrombosis","volume":"12","author":"Esmon","year":"1999","journal-title":"Baillieres Best Pract Res Clin Haematol"},{"key":"10.1016\/j.ajpath.2026.09.006_bib22","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/s41598-018-20220-8","article-title":"The inflammatory effects of TNF-alpha and complement component 3 on coagulation","volume":"8","author":"Page","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajpath.2026.09.006_bib23","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1055\/s-0038-1650683","article-title":"Augmented procoagulant activity in cancer patients, treated with recombinant interferon-gamma in addition to recombinant tumor necrosis factor-alpha and melphalan","volume":"76","author":"Mulder","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajpath.2026.09.006_bib24","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri3345","article-title":"Thrombosis as an intravascular effector of innate immunity","volume":"13","author":"Engelmann","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ajpath.2026.09.006_bib25","doi-asserted-by":"crossref","DOI":"10.1186\/ar4064","article-title":"Prothrombotic effects of tumor necrosis factor alpha in vivo are amplified by the absence of TNF-alpha receptor subtype 1 and require TNF-alpha receptor subtype 2","volume":"14","author":"Pircher","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ajpath.2026.09.006_bib26","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1824644","article-title":"Coagulation factor V is a marker of tumor-infiltrating immune cells in breast cancer","volume":"9","author":"Tinholt","year":"2020","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ajpath.2026.09.006_bib27","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1432-1033.1994.tb18678.x","article-title":"Human tumor necrosis factor mutants with preferential binding to and activity on either the R55 or R75 receptor","volume":"220","author":"Van Ostade","year":"1994","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.ajpath.2026.09.006_bib28","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/his.13311","article-title":"Clear cell renal cell carcinoma: validation of World Health Organization\/International Society of Urological Pathology grading","volume":"71","author":"Dagher","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.ajpath.2026.09.006_bib29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO;2-G","article-title":"The Heidelberg classification of renal cell tumours","volume":"183","author":"Kovacs","year":"1997","journal-title":"J Pathol"},{"key":"10.1016\/j.ajpath.2026.09.006_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.184","article-title":"Tubular epithelial cells in renal clear cell carcinoma express high RIPK1\/3 and show increased susceptibility to TNF receptor 1-induced necroptosis","volume":"7","author":"Al-Lamki","year":"2016","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ajpath.2026.09.006_bib31","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/j.1460-2075.1994.tb06327.x","article-title":"Dissociation of TNF-alpha cytotoxic and proinflammatory activities by p55 receptor- and p75 receptor-selective TNF-alpha mutants","volume":"13","author":"Barbara","year":"1994","journal-title":"EMBO J"},{"key":"10.1016\/j.ajpath.2026.09.006_bib32","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0962-8924(00)89088-1","article-title":"Two tumour necrosis factor receptors: structure and function","volume":"5","author":"Vandenabeele","year":"1995","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.ajpath.2026.09.006_bib33","first-page":"74","article-title":"The efficacy of sunitinib treatment of renal cancer cells is associated with the protein PHAX in vitro","volume":"9","author":"Al-Lamki","year":"2020","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.ajpath.2026.09.006_bib34","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1096\/fba.2019-00071","article-title":"Tumor necrosis factor receptor-2 signaling pathways promote survival of cancer stem-like CD133(+) cells in clear cell renal carcinoma","volume":"2","author":"Bradley","year":"2020","journal-title":"FASEB Bioadv"},{"key":"10.1016\/j.ajpath.2026.09.006_bib35","first-page":"673","article-title":"Clotting mechanisms and cancer: implications in thrombus formation and tumor progression","volume":"1","author":"Falanga","year":"2003","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.ajpath.2026.09.006_bib36","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s11523-021-00852-z","article-title":"Thromboembolism in patients with metastatic renal cell carcinoma treated with immunotherapy","volume":"16","author":"Sheng","year":"2021","journal-title":"Target Oncol"},{"key":"10.1016\/j.ajpath.2026.09.006_bib37","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1681\/ASN.2007060706","article-title":"TL1A both promotes and protects from renal inflammation and injury","volume":"19","author":"Al-Lamki","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ajpath.2026.09.006_bib38","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jtha.2023.02.029","article-title":"Cancer-associated thrombosis: enhanced awareness and pathophysiologic complexity","volume":"21","author":"Falanga","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ajpath.2026.09.006_bib39","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1067\/mva.2001.111996","article-title":"Renal cell carcinoma with extension of tumor thrombus into the vena cava: surgical strategy and prognosis","volume":"33","author":"Tsuji","year":"2001","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.ajpath.2026.09.006_bib40","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1161\/ATVBAHA.120.312674","article-title":"Recent insights into the regulation of coagulation and thrombosis","volume":"40","author":"Li","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpath.2026.09.006_bib41","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.arcmed.2021.07.003","article-title":"Roles of coagulation abnormalities and microthrombosis in sepsis: pathophysiology, diagnosis, and treatment","volume":"52","author":"Iba","year":"2021","journal-title":"Arch Med Res"},{"key":"10.1016\/j.ajpath.2026.09.006_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.886132","article-title":"Platelet-derived exosomes and atherothrombosis","volume":"9","author":"Wei","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.ajpath.2026.09.006_bib43","doi-asserted-by":"crossref","first-page":"27286","DOI":"10.1074\/jbc.M402159200","article-title":"ICln, a novel integrin alphaIIbbeta3-associated protein, functionally regulates platelet activation","volume":"279","author":"Larkin","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2026.09.006_bib44","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1111\/febs.16406","article-title":"The yin-yang roles of protease-activated receptors in inflammatory signalling and diseases","volume":"289","author":"Zhuo","year":"2022","journal-title":"FEBS J"},{"key":"10.1016\/j.ajpath.2026.09.006_bib45","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.avsg.2010.02.020","article-title":"Management of renal cell carcinoma with tumor thrombus in renal vein and the inferior vena cava","volume":"24","author":"Qi","year":"2010","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.ajpath.2026.09.006_bib46","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/path.2689","article-title":"VHL and HIF signalling in renal cell carcinogenesis","volume":"221","author":"Baldewijns","year":"2010","journal-title":"J Pathol"},{"key":"10.1016\/j.ajpath.2026.09.006_bib47","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1182\/blood-2015-09-671982","article-title":"Diverse roles of cell-specific hypoxia-inducible factor 1 in cancer-associated hypercoagulation","volume":"127","author":"Evans","year":"2016","journal-title":"Blood"},{"issue":"Suppl 3","key":"10.1016\/j.ajpath.2026.09.006_bib48","doi-asserted-by":"crossref","first-page":"S243","DOI":"10.1186\/ar569","article-title":"Signaling for survival and apoptosis in the immune system","volume":"4","author":"Mak","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1016\/j.ajpath.2026.09.006_bib49","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1042\/BJ20080476","article-title":"Regulation of hypoxia-inducible factor-1alpha by NF-kappaB","volume":"412","author":"van Uden","year":"2008","journal-title":"Biochem J"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944026002865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944026002865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:59:54Z","timestamp":1793109594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944026002865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":49,"alternative-id":["S0002944026002865"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2026.09.006","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor Necrosis Factor Receptor-2 Drives Tumoral Coagulation Factor Synthesis and Enhances Thrombosis in Clear-Cell Renal Cell Carcinoma","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2026.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of the American Society for Investigative Pathology.","name":"copyright","label":"Copyright"}]}}